Analytic Investors’s Elevance Health ELV Stock Holding History

Analytic Investors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,955	Closed	-$272K	–	630
2015 Q4	$272K	Buy	+1,955	New	+$269K	﹤0.01%	570
2015 Q1	–	Sell	-2,035	Closed	-$256K	–	552
2014 Q4	$256K	Buy	+2,035	New	+$251K	﹤0.01%	491
2014 Q2	–	Sell	-9,763	Closed	-$972K	–	543
2014 Q1	$972K	Hold	9,763	–	–	0.01%	355
2013 Q4	$902K	Buy	+9,763	New	+$867K	0.01%	315

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Analytic Investors's ELV Position: Q1 2016 in Review

Analytic Investors sold out of Elevance Health (ELV) in Q1 2016, closing a stake of 1,955 shares — an estimated $272K sold.

Analytic Investors first reported a position in ELV in Q4 2013 and held it in 4 quarters. The position peaked at $972K in Q1 2014. 772 funds tracked by Wall St. Rank hold ELV as of Q1 2016.

Analytic Investors reported no remaining Elevance Health position as of Q1 2016 after selling out during the quarter.
Analytic Investors sold 1,955 Elevance Health shares in Q1 2016, an estimated $272K.
Analytic Investors first reported a position in Elevance Health in Q4 2013 and held it in 4 quarters.
Analytic Investors's Elevance Health position peaked at $972K in Q1 2014.
772 funds tracked by Wall St. Rank held Elevance Health as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.